Integrating Radiomics with Genomics for Non-Small Cell Lung Cancer Survival Analysis

J Oncol. 2022 Aug 27;2022:5131170. doi: 10.1155/2022/5131170. eCollection 2022.


PURPOSE: The objectives of our study were to assess the association of radiological imaging and gene expression with patient outcomes in non-small cell lung cancer (NSCLC) and construct a nomogram by combining selected radiomic, genomic, and clinical risk factors to improve the performance of the risk model.

METHODS: A total of 116 cases of NSCLC with CT images, gene expression, and clinical factors were studied, wherein 87 patients were used as the training cohort, and 29 patients were used as an independent testing cohort. Handcrafted radiomic features and deep-learning genomic features were extracted and selected from CT images and gene expression analysis, respectively. Two risk scores were calculated through Cox regression models for each patient based on radiomic features and genomic features to predict overall survival (OS). Finally, a fusion survival model was constructed by incorporating these two risk scores and clinical factors.

RESULTS: The fusion model that combined CT images, gene expression data, and clinical factors effectively stratified patients into low- and high-risk groups. The C-indexes for OS prediction were 0.85 and 0.736 in the training and testing cohorts, respectively, which was better than that based on unimodal data.

CONCLUSIONS: Combining radiomics and genomics can effectively improve OS prediction for NSCLC patients.

PMID:36065309 | PMC:PMC9440821 | DOI:10.1155/2022/5131170


Related Posts

Leave a Reply

Your email address will not be published. Required fields are marked *

Generated by Feedzy